2Allen ME, Kopp BJ, Erstad BL. Stress ulcer in the postoperative period [J]. Am J Health Syst Pharm,2004,61 (6) :588 -596.
3Steinberg KP. Stress-related mueosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the inten- sive care unit [ J ]. Crit Care Med,2002,30 (6) : $362 - $364.
4Hsieh YH, Lin HJ,Tseng GY, et al. Poor responders to intravenous ome- prazote in patients with peptic ulcer bleeding[ J]. Hepatogas-troenterolo- gy,2004,51 (55) :316 -319.
5Garnett WR. Hi.,tory of acid suppression:focus on the hospital setting. Parmacotherapy ,2003,23 (10) :56S - 60S.
6Ferron GM,Mc Keand W,Mayer PR. Pharmeodynamic modeling of pan- toprazoles irreversible effect on gastric acid secretion in humans and rats [J]. Clin Pharmacol,2001,41:149 - 156.
7Metz DC. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion[ J]. Digestion,2000, 62:73 - 81.
